By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Germany's IUL Instruments has signed an agreement to exclusively market Pressure BioSciences' Pressure Cycling Technology sample preparation instruments and consumables in Germany and Switzerland.

In addition, IUL has non-exclusive rights to market and sell Pressure Bio's mechanical homogenization device, the Shredder SG3, and associated consumables in the same countries. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.